TheraRadar
Clinical-Stage Companies / Apsen Farmaceutica

Apsen Farmaceutica

Pre-Approval PRO BETA
12
Total Trials
6
Phase 3
3
Phase 2
0
Recruiting
133
Score

Pipeline by Phase

Phase 3
6
Phase 2
3
Phase 1
3

Therapeutic Focus

Healthy Volunteers Alopecia, Androgenetic Insomnia Insomnia Chronic Postsurgical Pain

Clinical Trials (12)

NCT07516561 Phase 3 NOT YET RECRUITING

Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia

Started: 7/7/2026

NCT04647435 Phase 3 COMPLETED

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction

Started: 5/13/2023

NCT03127592 Phase 3 TERMINATED

Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction

Started: 10/5/2020

NCT02112578 Phase 3 COMPLETED

Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin

Started: 11/1/2016

NCT01203371 Phase 3 WITHDRAWN

Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

Started: 1/1/2011

NCT04361461 Phase 3 WITHDRAWN

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Started: 4/30/2020

NCT07420816 Phase 2 NOT YET RECRUITING

Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder

Started: 3/26/2026

NCT04772781 Phase 2 COMPLETED

Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain

Started: 6/3/2022

NCT04637529 Phase 2 COMPLETED

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain

Started: 8/5/2022

NCT02956525 Phase 1 COMPLETED

Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions

Started: 4/1/2018

NCT04674735 Phase 1 WITHDRAWN

Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease

Started: 1/1/2023

NCT02956512 Phase 1 COMPLETED

Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

Started: 3/18/2019

Drug Candidates

APSMNF 1 APSMNF 2 Eniagor® APSTZD 1 APSTZD 2 APSTZD 3 APSTZD 4 Stilnox CR® Placebo APSCTC
Activity Status: Active
Last Trial Started: 7/7/2026
Last Trial Ended: 10/4/2024
Trials (12 months): 2
Completed Trials: 6
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.